Table 2.
Hearing assistive device type and processor, communication method, and deafness etiology for participants with hearing impairment fitted with cochlear implants (Study 1) or hearing aids (Study 2)
| Code | Device | Processor | Communication methoda | Etiology |
|---|---|---|---|---|
| Study 1 | ||||
| 2514 | Nucleus 24 K | Sprint | Total | Genetic |
| 2515 | Nucleus 24 Contour | Sprint | Cued speech | Auditory neuropathy |
| 2518 | Nucleus 24 Contour | Sprint | Oral | Genetic |
| 2519 | Med-El C 40+ | Tempo + | Oral | Waardenburg syndrome |
| 2523 | Nucleus 24 Contour | Sprint | Oral | Unknown |
| 2528 | Nucleus 24 Contour | Sprint | Total | Unknown |
| 2529 | Med-El C 40+ | Tempo + | Oral | Branchio-oto-renal syndrome |
| 2533 | Nucleus 24 Contour | Sprint | Oral | Genetic |
| 2534 | Nucleus 24 Contour | Sprint | Oral | Auditory neuropathy/LVA |
| 2535 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Mondini |
| 2536 | Clarion HiRes 90 k | PSP | Total | Unknown |
| 2537 | Nucleus Freedom—Straight | Freedom | Total | VATER syndrome |
| 2540 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Unknown |
| 2542 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Unknown |
| 2543 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Unknown |
| 2795 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Genetic |
| 2813 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Unknown |
| 3029 | Advanced Bionics HiRes 90 K | PSP/Harmony | Oral | Unknown |
| 3058 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Unknown |
| 3098 | Nucleus Freedom—Contour Adv. | Freedom | Oral | Unknown |
| Study 2 | ||||
| 2114 | Oticon Gaia BTEs | Oral | Genetic | |
| 2489 | Phonak Maxx 211 BTE | Total | Unknown | |
| 2491 | Phonak Maxx 311 BTEs | Unavailable | Unavailable | |
| 2493 | Oticon Gaia BTEs | Unavailable | Unavailable | |
| 2744 | Phonak Power Maxx 411 BTEs | Unavailable | Unavailable | |
| 2769 | Phonak Maxx 311 BTEs | Oral/Signed Exact English | mitochondrial myopathy/LVA | |
| 2884 | Phonak Maxx 311 BTEs | Total | Unknown | |
| 2891 | Oticon Gaia Power BTEs | Oral | Leigh's disease | |
| 3029 | Oticon Tego Pro BTEs | Oral | Unknown | |
| 3031 | Oticon Sumo BTE (L), Oticon Tego Pro BTE | Oral/American Sign Language | Unknown | |
| 3699 | Oticon Tego Pro BTEs | Oral | Unknown | |
Note. LVA = large vestibular aqueduct; Adv. = advanced; VATER = vertebral, anus, trachea, esophagus, and/or renal abnormalities; BTE = behind-the-ear.
a
Communication method describes exclusively spoken language (oral) or a combination of spoken language with Signed Exact English (total).